We are live on ! Find out more
IMGO

Imago BioSciences, Inc. Common stock

Delisted

IMGO was delisted on the 10th of January, 2023.

106 hedge funds and large institutions have $1.05B invested in Imago BioSciences, Inc. Common stock in 2022 Q4 according to their latest regulatory filings, with 56 funds opening new positions, 25 increasing their positions, 18 reducing their positions, and 15 closing their positions.

New
Increased
Maintained
Reduced
Closed

273% more first-time investments, than exits

New positions opened: 56 | Existing positions closed: 15

150% more funds holding in top 10

Funds holding in top 10: 25 (+3)

120% more capital invested

Capital invested by funds: $478M → $1.05B (+$576M)

63% more funds holding

Funds holding: 65106 (+41)

39% more repeat investments, than reductions

Existing positions increased: 25 | Existing positions reduced: 18

100% less call options, than puts

Call options by funds: $0 | Put options by funds: $910K

Holders
106
Holders Change
+41
Holders Change %
+63.08%
% of All Funds
1.7%
Holding in Top 10
5
Holding in Top 10 Change
+3
Holding in Top 10 Change %
+150%
% of All Funds
0.08%
New
56
Increased
25
Reduced
18
Closed
15
Calls
Puts
$910K
Net Calls
-$910K
Net Calls Change
-$910K
Name Holding Trade Value Shares
Change
Change in
Stake
CM
51
Crystalline Management
Canada
$1.62M +$1.13M +45,100 New
Public Sector Pension Investment Board (PSP Investments)
52
Public Sector Pension Investment Board (PSP Investments)
Quebec, Canada
$1.62M +$1.13M +45,000 New
RhumbLine Advisers
53
RhumbLine Advisers
Massachusetts
$1.33M +$52.5K +2,101 +6%
Squarepoint
54
Squarepoint
New York
$1.25M +$868K +34,707 New
Verition Fund Management
55
Verition Fund Management
Connecticut
$1.21M +$845K +33,790 New
Swiss National Bank
56
Swiss National Bank
Switzerland
$1.17M +$20K +800 +3%
HM
57
Harvest Management
New York
$1.17M +$813K +32,500 New
GH
58
GAM Holding
Switzerland
$1.06M +$735K +29,408 New
WMSA
59
Weiss Multi-Strategy Advisers
New York
$1.04M +$722K +28,893 New
BCM
60
BCK Capital Management
Connecticut
$953K +$663K +26,500 New
RJA
61
Raymond James & Associates
Florida
$938K
AA
62
ALPS Advisors
Colorado
$824K +$114K +4,556 +25%
California State Teachers Retirement System (CalSTRS)
63
California State Teachers Retirement System (CalSTRS)
California
$799K +$5.65K +226 +1%
Ohio Public Employees Retirement System (OPERS)
64
Ohio Public Employees Retirement System (OPERS)
Ohio
$755K +$525K +21,000 New
TI
65
Telemetry Investments
New York
$694K +$482K +19,291 New
New York State Common Retirement Fund
66
New York State Common Retirement Fund
New York
$683K -$650 -26 -0.1%
UBS AM
67
UBS AM
Illinois
$661K +$460K +18,391 New
RCM
68
Regency Capital Management
Hawaii
$647K -$250 -10 -0.1%
SC
69
Sagefield Capital
Texas
$640K +$445K +17,800 New
JP Morgan Chase
70
JP Morgan Chase
New York
$569K -$17.3K -691 -4%
VF
71
Virtu Financial
New York
$539K +$375K +15,004 New
MIM
72
MetLife Investment Management
New Jersey
$506K -$106K -4,246 -23%
SO
73
STRS Ohio
Ohio
$467K +$325K +13,000 New
State of Wisconsin Investment Board
74
State of Wisconsin Investment Board
Wisconsin
$467K -$21.3K -852 -6%
PCM
75
PenderFund Capital Management
British Columbia, Canada
$453K +$233K +9,300 New

IMGO Hedge Fund Activity: Q4 2022 in Review

106 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Imago BioSciences, Inc. Common stock (IMGO) for Q4 2022, worth a combined $1.05B — up 120% from $478M a quarter earlier.

Buyers outnumbered sellers: 56 funds opened new IMGO positions and 15 closed out — a net gain of 41 holders — while 25 added to existing stakes and 18 trimmed.

The largest buyer was Frazier Life Sciences Management, adding an estimated $25.4M. The largest seller was Fidelity Investments, cutting an estimated $127M.

  • 106 institutional investors held Imago BioSciences, Inc. Common stock (IMGO) as of Q4 2022, up from 65 in Q3 2022.
  • Funds reported $1.05B of Imago BioSciences, Inc. Common stock stock for Q4 2022, up 120% quarter-over-quarter.
  • 56 funds opened new Imago BioSciences, Inc. Common stock positions in Q4 2022 and 15 closed out, a net change of +41 holders.
  • The largest Imago BioSciences, Inc. Common stock buyer in Q4 2022 was Frazier Life Sciences Management, an estimated $25.4M added.
  • The largest Imago BioSciences, Inc. Common stock seller in Q4 2022 was Fidelity Investments, an estimated $127M sold.

Based on aggregated 13F filings for Q4 2022.